New microscope at Mayo Clinic brings researchers one step closer to curing breast cancer
Researchers are one step closer to curing breast cancer at the Mayo Clinic with a new microscope called the Nanostring GeoMX.
"We are excited to be pioneers in the evaluation of a brand-new technology," Dr. Edith Perez, an oncologist at the Mayo Clinic, said.
The Mayo Clinic is now one of four facilities worldwide to use this microscope.
"It's mainly telling us what are the key immune features that determine whether a patient is going to survive or not survive," Dr. Aubrey Thompson, an oncology researcher, said. "That then leads us to figure out how to manipulate those immune features to decrease breast cancer mortality."
Forty-four patients have volunteered samples of their cancerous tumors to be used with this microscope. Some of these patients have reacted well to previous treatments, others haven't.
This new microscope can analyze those immune cells to try and find the key factors that lead some patients to survival, and others unresponsive.
The microscope is partially funded by the DONNA Foundation, founded by Donna Deegan. Deegan is a breast cancer survivor and knows what it's like to be in a patient's shoes.
"I want everyone to feel hopeful," Deegan said. "When you look at this machine and the way it is helping us to understand the immune system -- if we could actually somehow get the immune system to work in our favor when it comes to cancer -- and I believe that's the eventual goal, I want everyone to be excited about that future. Every day, those advances are happening."
Over $3 million have been donated to the Mayo Clinic for breast cancer research from the foundation. Tuesday, she is hopeful as she sees where her supporters' money is being used at the Mayo Clinic.
"I believe now that we understand so much more and with machines like this," Deegan said. "I think we are going to see exponential growth in new treatments and cures."
Dr. Perez is confident this immune system research may help in other cancer research as well.
"It's really expanding to other tumor types," Perez said. "It's one of those things, one technology can help all."
During 'Breast Cancer Awareness Month' particularly, this could be truly encouraging news. Researchers at The Mayo Clinic have been testing a vaccine that we've heard has removed cancer cells in Lee Mercker, a breast cancer patient
Nowadays, Cancer is a disease which is very usual to hear among people, while earlier, it was the one which was presented in the human body very rarely. Though it has medications across the world
Walz sending a message to the tobacco industry during a press conference in St. Paul Thursday after a spike in vaping related lung injuries across the country including 61 cases in the state. According to the
ROCHESTER, Minn. - Overturning the prevailing view of the mechanism behind the vaping-related serious lung injury that has local and national health officials on high alert, the Mayo Clinic on Wednesday released findings from the
SCOTTSDALE, AZ (3TV/CBS 5) -- A study from the Mayo Clinic sheds new light on the dangers of vaping. The study, which was published in The New England Journal of Medicine, finds that lung injuries from
A study released by the Mayo Clinic on Wednesday showed that lung illnesses from vaping are most likely a "direct chemical injury," similar to the dangers of being exposed to toxic chemical fumes and poisonous
Dear Mayo Clinic: I have osteoarthritis in my knee that continues to worsen. Would a steroid injection help my knee pain? How long does the treatment last, and how often can it be
More News in Research
Oxidized starch is a very versatile product. It is mainly used in the cooking process as well as it increases the printability of materials especially paper.Upsurging Demand in Pharmaceutical Industry Owing To Research and
Research at a Glance: Melbourne researchers identify three simple markers that can be used clinically to predict the onset or resolution of weight problems by adolescence Combining these three factors may help clinicians target care to those
"What we have in mucus is a therapeutic gold mine." Flu season is here and in turn, we've returned to the familiar sights and sounds of runny snot and thick phlegm. However, most
A low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of injury, according to a major study published in The Lancet.
Scientists have developed a molecular "clock" that could reshape how pediatricians measure and monitor childhood growth and potentially allow for an earlier diagnosis of life-altering development disorders. The research, published this week in PNAS, describes how